• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

SGLT2 (sodium-glucose cotransporter 2) inhibitors produce a distinctive pattern of benefits
on the evolution and progression of cardiomyopathy and nephropathy, which is …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Purpose Genetic testing has advanced significantly since the publication of the 2011
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the …

Youth and adult participation in sports continues to increase, and athletes may be
diagnosed with potentially arrhythmogenic cardiac conditions. This international …

Background Metformin, a first-line medication for type 2 diabetes, might also have a
protective effect against ageing-related diseases, but so far little experimental evidence is …

Danon disease is a rare X-linked autophagic vacuolar cardioskeletal myopathy associated
with severe heart failure that can be accompanied with extracardiac neurologic, skeletal …

Abstract Purpose of Review We describe the most common phenocopies of hypertrophic
cardiomyopathy, their pathogenesis, and clinical presentation highlighting similarities and …